Second- and Further-Line Therapy with Erlotinib in Patients with Advanced Non-Small-Cell Lung Cancer in Daily Clinical Practice

Introduction. The aim of this retrospective study was to examine effect of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) in second-line and further therapy in daily clinical practice. Methods. Patients with histologically or cytologically proven NSCLC (n = 84) treated with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Krainhöfer, Josephine, Walther, Mario, Steinert, Matthias, Reissig, Angelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084583/
https://www.ncbi.nlm.nih.gov/pubmed/25028671
http://dx.doi.org/10.1155/2014/987150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084583/
https://www.ncbi.nlm.nih.gov/pubmed/25028671
http://dx.doi.org/10.1155/2014/987150

Ejemplares similares